| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $655,765 ) |
| | 2024 | 2024 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 5 | NIH | 3/13/2024 | $216,402 |
| | 2024 | 2024 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 5 | NIH | 3/13/2024 | $439,363 |
| | 2024 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI162151 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 3 | NIH | 12/14/2023 | $0 |
| | 2024 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI172541 | Sustained Release of Potent Antiviral Prodrugs for HIV Prevention | 000 | 1 | NIH | 2/21/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,128,266 ) |
| | 2023 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI154561 | A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection | 000 | 4 | NIH | 7/21/2023 | $890,560 |
| | 2023 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 4 | NIH | 3/7/2023 | $246,408 |
| | 2023 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 4 | NIH | 3/7/2023 | $500,285 |
| | 2023 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI172541 | Sustained Release of Potent Antiviral Prodrugs for HIV Prevention | 000 | 1 | NIH | 5/30/2023 | $725,049 |
| | 2023 | 2023 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI162151 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 3 | NIH | 6/2/2023 | $765,964 |
|
| Issue Date FY: 2022 ( Subtotal = $2,947,658 ) |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 001 | 3 | NIH | 4/25/2022 | $24,442 |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 3 | NIH | 3/8/2022 | $446,618 |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 3 | NIH | 3/8/2022 | $219,975 |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 001 | 3 | NIH | 4/25/2022 | $49,625 |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI154561 | A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection | 000 | 3 | NIH | 7/20/2022 | $904,172 |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI162151 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 2 | NIH | 6/28/2022 | $781,612 |
| | 2022 | 2022 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI162151 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 001 | 2 | NIH | 8/11/2022 | $521,214 |
| | 2022 | 2019 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 5 | NIH | 12/21/2021 | $0 |
| | 2022 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 5 | NIH | 3/24/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,404,206 ) |
| | 2021 | 2021 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 001 | 2 | NIH | 8/27/2021 | $4,916 |
| | 2021 | 2021 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 001 | 2 | NIH | 8/27/2021 | $9,981 |
| | 2021 | 2021 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 2 | NIH | 2/24/2021 | $240,886 |
| | 2021 | 2021 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 2 | NIH | 2/24/2021 | $489,072 |
| | 2021 | 2021 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI154561 | A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection | 000 | 2 | NIH | 7/29/2021 | $877,357 |
| | 2021 | 2021 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI162151 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 1 | NIH | 7/12/2021 | $781,994 |
|
| Issue Date FY: 2020 ( Subtotal = $1,673,403 ) |
| | 2020 | 2020 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 1 | NIH | 5/4/2020 | $508,664 |
| | 2020 | 2020 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01HD101344 | Next Generation Multipurpose Prevention Technology: An Intravaginal Ring for HIV Prevention and Nonhormonal Contraception | 000 | 1 | NIH | 5/4/2020 | $250,535 |
| | 2020 | 2020 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI154561 | A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection | 000 | 1 | NIH | 8/28/2020 | $914,204 |
| | 2020 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 5 | NIH | 12/11/2019 | $0 |
| | 2020 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 001 | 5 | NIH | 8/10/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $838,173 ) |
| | 2019 | 2019 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 001 | 5 | NIH | 5/30/2019 | $838,173 |
| | 2019 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 5 | NIH | 4/2/2019 | $0 |
| | 2019 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 4 | NIH | 1/23/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $4,554,850 ) |
| | 2018 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 4 | NIH | 5/17/2018 | $838,140 |
| | 2018 | 2018 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 5 | NIH | 8/6/2018 | $3,716,710 |
|
| Issue Date FY: 2017 ( Subtotal = $4,486,748 ) |
| | 2017 | 2017 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 4 | NIH | 6/26/2017 | $3,651,503 |
| | 2017 | 2017 | OAK CREST INSTITUTE OF SCIENCE | 132 W CHESTNUT AVE | MONROVIA | CA | 91016-3412 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 3 | NIH | 5/19/2017 | $835,245 |
|
| Issue Date FY: 2016 ( Subtotal = $5,247,575 ) |
| | 2016 | 2016 | OAK CREST INSTITUTE OF SCIENCE | 2275 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 3 | NIH | 7/15/2016 | $4,434,672 |
| | 2016 | 2016 | OAK CREST INSTITUTE OF SCIENCE | 2275 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 2 | NIH | 5/23/2016 | $812,903 |
|
| Issue Date FY: 2015 ( Subtotal = $4,201,008 ) |
| | 2015 | 2015 | OAK CREST INSTITUTE OF SCIENCE | 2275 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | R01AI120748 | Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | 000 | 1 | NIH | 6/15/2015 | $867,958 |
| | 2015 | 2015 | OAK CREST INSTITUTE OF SCIENCE | 2275 EAST FOOTHILL BOULEVARD | PASADENA | CA | 91107 | LOS ANGELES | USA | U19AI113048 | Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention | 000 | 2 | NIH | 7/21/2015 | $3,333,050 |
|
|
